Atheroklefit Bio capsules, 60 pcs.

The action of Atheroklefit is due to its constituent components.

The flavonoids contained in red clover help cleanse blood vessels of cholesterol, thus preventing the development of atherosclerosis.

As a result of using Ateroklefit favorable changes in lipid metabolism, strengthening of the walls of blood vessels, reduction of thrombosis and lowering of blood cholesterol levels are observed.

Aterocelefit according to reviews is well tolerated and reduces the manifestation of various symptoms of vascular disorders – palpitations, dizziness and tinnitus.

Indications

Biologically active food supplement.

Recommended as an additional source of flavonoids, vitamins: C, PP.

Pharmacological effect

The action of Atheroclephitis is determined by its constituent components.

Flavonoids contained in red clover help cleanse blood vessels of cholesterol, thereby preventing the development of atherosclerosis.

As a result of the use of Atheroclephitis, favorable changes in lipid metabolism, strengthening of the walls of blood vessels, a decrease in thrombus formation and a decrease in cholesterol levels in the blood are observed.

According to reviews, atheroclephitis is well tolerated and reduces the manifestation of various symptoms of vascular disorders – palpitations, dizziness and tinnitus.

Composition

Dioscorea extract,
capsule components (food additives): gelatin; iron oxide and titanium dioxide (dyes);
ascorbic acid,
clover extract,
nicotinic acid (vitamin PP),
extract of flowers and leaves of hawthorn,
amorphous silicon dioxide (anti-caking agent),
routine,
Vegetable magnesium stearate (anti-caking agent).

Pregnancy

Contraindicated during pregnancy and breastfeeding.

Contraindications

Individual intolerance to components;
pregnancy;
breastfeeding period.

Short product description

Dietary supplement Not a medicine.
Before use, it is recommended to consult a doctor (specialist).

Storage conditions

At a temperature not exceeding 25 °C.

Shelf life

3 years.

Manufacturer

Evalar CJSC, Russia